Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK-3 inhibitor 4

🥰Excellent
Catalog No. T77341Cas No. 2227279-83-4

GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5). It effectively reduces Tau protein levels and can be used in the study of Alzheimer's disease.

GSK-3 inhibitor 4

GSK-3 inhibitor 4

🥰Excellent
Purity: 98.77%
Catalog No. T77341Cas No. 2227279-83-4
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5). It effectively reduces Tau protein levels and can be used in the study of Alzheimer's disease.
Pack SizePriceAvailabilityQuantity
1 mg$350In Stock
5 mg$970In Stock
10 mg$1,200In Stock
25 mg$1,590In Stock
50 mg$1,980In Stock
100 mg$2,500In Stock
500 mg$3,930In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "GSK-3 inhibitor 4"

Select Batch
Purity:98.77%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5). It effectively reduces Tau protein levels and can be used in the study of Alzheimer's disease.
Targets&IC50
GSK-3β:0.56 nM, GSK-3α:0.45 nM, CDK2:0.47 μM, CDK5:0.68 μM
In vitro
GSK-3 inhibitor 4 (compound 40) demonstrates excellent selectivity and efficacy against CDK2 (840-fold, IC50 = 0.47 μM), CDK5 (1200-fold, IC50 = 0.68 μM), GSK-3β (IC50 = 0.56 nM), and GSK-3α (IC50 = 0.45 nM). It also exhibits good permeability and a high capacity for binding to plasma proteins and brain tissue due to its lipophilicity.[1]
In vivo
GSK-3 inhibitor 4 (10 mg/kg; p.o.) reduced pTau396 by 37% when administered orally as a nanosuspension. GSK-3 inhibitor 4 (2 mg/kg, i.v.; 10 mg/kg, p.o.) exhibits low to moderate clearance (15.8 to 23.3 mL/min/kg) and is well absorbed orally in solution.[1]
Chemical Properties
Molecular Weight403.38
FormulaC22H15F2N5O
Cas No.2227279-83-4
SmilesN(C(=O)C1=NC(NC2=CC=C(F)C=C2)=NC=C1)C=3C(=CC=NC3)C4=CC=C(F)C=C4
Relative Density.1.401 g/cm3 at 20℃ (Predicted)
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (123.95 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4791 mL12.3953 mL24.7905 mL123.9526 mL
5 mM0.4958 mL2.4791 mL4.9581 mL24.7905 mL
10 mM0.2479 mL1.2395 mL2.4791 mL12.3953 mL
20 mM0.1240 mL0.6198 mL1.2395 mL6.1976 mL
50 mM0.0496 mL0.2479 mL0.4958 mL2.4791 mL
100 mM0.0248 mL0.1240 mL0.2479 mL1.2395 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK-3 inhibitor 4 | purchase GSK-3 inhibitor 4 | GSK-3 inhibitor 4 cost | order GSK-3 inhibitor 4 | GSK-3 inhibitor 4 chemical structure | GSK-3 inhibitor 4 in vivo | GSK-3 inhibitor 4 in vitro | GSK-3 inhibitor 4 formula | GSK-3 inhibitor 4 molecular weight